Symbol | Exchange | Currency |
|---|
As of March 2, 2023, European Biotech Acquisition Corp. was acquired by Oculis SA, in a reverse merger transaction. European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on business in the life sciences industry in Europe. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Sell | Neutral | Strong Buy | Strong Buy | Strong Buy |
| Summary | Neutral | Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 192.20 | 199.31 | 191.82 | +1.05 | +0.55% | 100.60M | NASDAQ | |||
| 159.55 | 161.55 | 158.73 | +1.72 | +1.09% | 38.23M | NASDAQ | |||
| 60.20 | 60.39 | 59.81 | +0.15 | +0.25% | 6.51M | NYSE | |||
| 205.55 | 207.88 | 202.67 | +5.74 | +2.87% | 18.07M | NASDAQ | |||
| 105.71 | 106.30 | 104.46 | +2.34 | +2.26% | 21.60M | NASDAQ | |||
| 278.75 | 281.05 | 275.34 | +6.46 | +2.37% | 20.59M | NASDAQ | |||
| 40.27 | 40.50 | 40.13 | +0.26 | +0.66% | 8.15M | NYSE | |||
| 100.53 | 102.43 | 99.35 | +2.95 | +3.02% | 56.62M | NASDAQ | |||
| 99.16 | 101.06 | 98.99 | +0.46 | +0.47% | 34.45M | NASDAQ | |||
| 161.48 | 165.85 | 161.10 | -1.73 | -1.06% | 1.19M | NASDAQ | |||
| 270.32 | 274.99 | 269.56 | +5.64 | +2.13% | 37.55M | NASDAQ | |||
| 8.29 | 8.56 | 8.29 | +0.09 | +1.04% | 16.06M | NYSE | |||
| 106.37 | 107.10 | 105.41 | +2.15 | +2.06% | 16.45M | NASDAQ | |||
| 45.93 | 46.94 | 45.45 | +0.97 | +2.17% | 10.99M | NYSE | |||
| 10.26 | 10.26 | 10.26 | 0.00 | 0.00% | 0.00 | NYSE |